REFLECTION: A Clinical Practice Learning Program for Galleri®
Sponsored by GRAIL, Inc.
About this trial
Last updated a year ago
Study ID
GRAIL-MA-001
Status
Recruiting
Type
Observational [Patient Registry]
Placebo
No
Accepting
22+ Years
All
Trial Timing
Started 4 years ago
What is this trial about?
REFLECTION is a multi-center, prospective, non-interventional, cohort study that will
enroll approximately 17,000 individuals who have opted to be screened with Galleri®, a
blood-based, multi-cancer early detection (MCED) test in routine clinical settings. The
purpose of the study is to understand the real-world experience of Galleri® in clinical
settings.
What are the participation requirements?
Inclusion Criteria
Participants are eligible to be included in the study only if all of the following criteria apply: - Participant has the ability to understand and the willingness to sign a written informed consent form (ICF); - Participant is at least 22 years old at the time of consent; - A provider or their designee has ordered the Galleri® test; and - Participant has the ability to comprehend the participant questionnaires.
Exclusion Criteria
- There are no exclusions